Accurate. Sustainable. Solution.
With Solana, you can sustain your molecular testing of critical assays for which you might be considering alternate methods. Coupled with the power of Virena®
cloud
based analytics, you can quickly implement a more complete solution to protect the health of your patients and your facility.
9.4” x 9.4” x 5.9” Deployable
For more information contact
Easy, exible work ow – Integrated seamlessly for single specimen or high-throughput batching up to 12 tests at a time
Minimal training – Get up and running quickly Enhanced diagnostics
featuring data analytics and surveillance
*SARS-CoV-2 In uenza A+B RSV + hMPV Respiratory Viral Panel Strep Complete C. dif cile
GAS GBS
HSV 1+2/VZV Bordetella Complete Trichomonas
*THIS TEST IS AVAILABLE FOR SALE IN THE USA UNDER EMERGENCY USE AUTHORIZATION. The Solana SARS-CoV-2 Assay has not been FDA cleared or approved, but has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This assay is only authorized for the duration of the declaration that circumstances exist justi- fying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner.
AD1003800EN00 (02/22)
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
